Sublingual Administration of PPI

NCT01926600 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-08-21

No results posted yet for this study

Summary

Compare 24-hour intragastric pH and therapeutic effectiveness of proton pump inhibitor (PPI) among different administration methods: per oral (PO), intravenous (IV), and sublingual (SL).

Conditions

  • Gastric or Duodenal Ulcer

Sponsors & Collaborators

  • The Catholic University of Korea

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01926600 on ClinicalTrials.gov